Publications by authors named "Esther Falco"

Claim this Profile
R
Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain.
Rocio Garcia-Carbonero, Beatriz González Astorga, Rosario Vidal Tocino, Débora Contreras Toledo, Carles Pericay

Clin Transl Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
Ana Fernández Montes, Vicente Alonso Orduña, Elena Asensio Martínez, Nuria Rodríguez Salas, Esperanza Torres

Oncologist· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study.
Carles Pericay, Ana Fernández Montes, Vicente Alonso Orduña, Ismael Macias Declara, Elena Asensio Martínez

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation- and Metastasis-Related Proteins Expression Changes in Early Stages in Tumor and Non-Tumor Adjacent Tissues of Colorectal Cancer Samples.
Marina Alorda-Clara, Margalida Torrens-Mas, Reyniel Hernández-López, Javier M Ibarra de la Rosa, Esther Falcó

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial Function Differences between Tumor Tissue of Human Metastatic and Premetastatic CRC.
Reyniel Hernández-López, Margalida Torrens-Mas, Daniel G Pons, Maria M Company, Esther Falcó

Biology (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial.
Fernando Rivera, Marta Izquierdo-Manuel, Pilar García-Alfonso, Eva Martínez de Castro, Javier Gallego

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease.
Jorge Aparicio, Francis Esposito, Sara Serrano, Esther Falco, Pilar Escudero

J Clin Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.
Ruth Vera, María Luisa Gómez, Juan Ramón Ayuso, Joan Figueras, Pilar García-Alfonso

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antioxidant enzymes change in different non-metastatic stages in tumoral and peritumoral tissues of colorectal cancer.
Auba Gaya-Bover, Reyniel Hernández-López, Marina Alorda-Clara, Javier M Ibarra de la Rosa, Esther Falcó

Int J Biochem Cell Biol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
Joan Maurel, Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Antonieta Salud

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
Pilar García-Alfonso, Manuel Benavides, Esther Falcó, Andrés Muñoz, Auxiliadora Gómez

Oncologist· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response.
Reyniel Hernández-López, Margalida Torrens-Mas, Daniel G Pons, Maria M Company, Esther Falcó

Free Radic Biol Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Vicente Alonso, Pilar Escudero, Carlos Fernández-Martos, Antonia Salud, Miguel Méndez

Neoplasia· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Antonio Irigoyen, Javier Gallego, Carmen Guillén Ponce, Ruth Vera, Vega Iranzo

Eur J Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer.
Alberto Muñoz, Carles Pericay, Carlos García-Girón, Vicente Alonso, Rosario Dueñas

Oncol Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of hand-foot syndrome with capecitabine in combination with chemotherapy as first-line treatment in patients with advanced and/or metastatic gastric cancer suitable for treatment with a fluoropyrimidine-based regimen.
Carlos Gómez-Martin, Antonio Sánchez, Antonio Irigoyen, Beatriz Llorente, Begoña Pérez

Clin Transl Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.
Salvador Pita Fernández, Sonia Pértega Díaz, Beatriz López Calviño, Paloma González Santamaría, Teresa Seoane Pillado

BMC Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis